Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

cGMP-selective PDE inhibitors under study at Bayer

Oct. 18, 2002

Duloxetine in urinary stress incontinence

Oct. 17, 2002

Novel potassium channel openers under study at Abbott

Oct. 17, 2002

Novel agents for urinary incontinence covered by Boehringer Ingelheim patent

Oct. 15, 2002

Merck patent covers novel alpha1A-adrenoceptor antagonists and their use in BPH

Oct. 14, 2002

Dutasteride approved for launch as first dual-acting 5alpha-reductase inhibitor for BPH

Oct. 11, 2002

Novel small-molecule leads targeting the V2 vasopressin receptor

Oct. 11, 2002

Reduction of RCN incidence with fenoldopam mesilate after contrast angiography

Oct. 10, 2002

Keryx extends manufacturing and negotiating rights for KRX-101

Oct. 8, 2002

Positive clinical results for PT-141 in moderate to severe MED

Oct. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...